Treatment of Apolipoprotein L1 with CRISPR and Chinese Medication
Summary: Chronic Kidney Disease and Focal Segmental Glomerulosclerosis are affecting humans all over the globe. Apolipoprotein L1 is the cause of kidney diseases, especially in African ancestry. Through CRISPR and Chinese Medication, kidney disease can be cured or controlled. CRISPR can target the risk variant and eliminate the high risk genotype from the variant. Chinese … Read more